Julia W. Erath

Apixaban for Stroke Prevention in Subclinical Atrial Fibrillation

Jeff S. Healey, Renato D. Lópes, Christopher B. Granger et al. · New England Journal of Medicine · 2023 · 371 citations · Full text

Effects of Upgrade Versus De Novo Cardiac Resynchronization Therapy on Clinical Response and Long-Term Survival

Máté Vámos, Julia W. Erath, Zsolt Bári et al. · Circulation Arrhythmia and Electrophysiology · 2017 · 41 citations · Full text

Apixaban versus aspirin for stroke prevention in people with subclinical atrial fibrillation and a history of stroke or transient ischaemic attack: subgroup analysis of the ARTESiA randomised controlled trial

Ashkan Shoamanesh, Thalia S. Field, Shelagh B. Coutts et al. · The Lancet Neurology · 2025 · 41 citations

Thrombosis, Cardiovascular Disease, Ischemic Stroke +14

The wearable cardioverter-defibrillator in a real-world clinical setting: experience in 102 consecutive patients

Julia W. Erath, Máté Vámos, Abdul Sami Sirat et al. · Clinical Research in Cardiology · 2016 · 38 citations

Consecutive Patients, Heart Failure, Cardiopulmonary Resuscitation +11

Protected risk stratification with the wearable cardioverter-defibrillator: results from the WEARIT-II-EUROPE registry

Christian Veltmann, Stefan Winter, David Duncker et al. · Clinical Research in Cardiology · 2020 · 29 citations · Full text